Vorinostat and bortezomib as third-line therapy in patients with advanced non-small cell lung cancer: a Wisconsin Oncology Network Phase II study.

Tien Hoang; Toby C Campbell; Chong Zhang; Kyungmann Kim; Jill M Kolesar; Kurt R Oettel; Jules H Blank; Emily G Robinson; Harish G Ahuja; Ron J Kirschling; Peter H Johnson; Michael S Huie; Mary E Wims; Martha M Larson; Hilary R Hernan; Anne M Traynor

首页> 外文期刊>Investigational new drugs. >Vorinostat and bortezomib as third-line therapy in patients with advanced non-small cell lung cancer: a Wisconsin Oncology Network Phase II study.

【24h】

Vorinostat and bortezomib as third-line therapy in patients with advanced non-small cell lung cancer: a Wisconsin Oncology Network Phase II study.

机译：伏立诺他和硼替佐米作为晚期非小细胞肺癌患者的三线治疗：威斯康星州肿瘤网络II期研究。

获取原文

获取原文并翻译 | 示例

获取外文期刊封面目录资料

开具论文收录证明 >>

文献代查 >>

文献数据库（团队版） >>

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

Bortezomib and vorinostat displayed minimal anti-tumor activity as third-line therapy in NSCLC. We do not recommend this regimen for further investigation in unselected patients.

机译：在非小细胞肺癌中，硼替佐米和伏立诺他作为三线治疗药物显示出最小的抗肿瘤活性。我们不建议将此方案用于未选患者的进一步研究。

著录项

来源
《Investigational new drugs.》 |2014年第1期|共5页
作者
Tien Hoang; Toby C Campbell; Chong Zhang; Kyungmann Kim; Jill M Kolesar; Kurt R Oettel; Jules H Blank; Emily G Robinson; Harish G Ahuja; Ron J Kirschling; Peter H Johnson; Michael S Huie; Mary E Wims; Martha M Larson; Hilary R Hernan; Anne M Traynor;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类药学;
关键词

相似文献

外文文献
中文文献
专利

1. Vorinostat and bortezomib as third-line therapy in patients with advanced non-small cell lung cancer: a Wisconsin Oncology Network Phase II study. [J] . Tien Hoang, Toby C Campbell, Chong Zhang, Investigational new drugs. . 2014,第1期

机译：伏立诺他和硼替佐米作为晚期非小细胞肺癌患者的三线治疗：威斯康星州肿瘤网络II期研究。
2. Vorinostat (NSC# 701852) in patients with relapsed non-small cell lung cancer: a Wisconsin Oncology Network phase II study. [J] . Traynor AM, Dubey S, Eickhoff JC, Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2009,第4期

机译：复发非小细胞肺癌患者的Vorinostat（NSC＃701852）：威斯康星州肿瘤网络II期研究。
3. Phase I/II study of vinorelbine and exisulind as first-line treatment of advanced non-small cell lung cancer in patients at least 70 years old: a wisconsin oncology network study. [J] . Attia S, Traynor AM, Kim K, Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2008,第9期

机译：长春瑞滨和exisulind作为一线治疗至少70岁的晚期非小细胞肺癌的I / II期研究：威斯康星州肿瘤学网络研究。
4. The clinical efficacy of transfusion of cytokine-induced killer cells combined with chemotherapy and XiaoJi decoction in patients with stage IIIB/IV non-small cell lung cancer [C] . Liuning Li, Jiaying Liu, Xiaoshu Chai, IEEE International Conference on Bioinformatics and Biomedicine . 2014

机译：细胞因子诱导的杀伤细胞输注结合化学疗法和消积汤治疗IIIB / IV期非小细胞肺癌的临床疗效
5. Symptoms Leading to Nutritional Risk in Advanced Non-Small Cell Lung Cancer Patients: The Importance of Nutritional Screening in the Advanced Lung Cancer Population [D] . Swinton, Nelda. 2009

机译：导致晚期非小细胞肺癌患者营养风险的症状：在晚期肺癌人群中进行营养筛查的重要性
6. Vorinostat and bortezomib as third-line therapy in patients with advanced non-small cell lung cancer: a Wisconsin Oncology Network Phase II study [O] . Tien Hoang, Toby C. Campbell, Chong Zhang, -1

机译：伏立诺他和硼替佐米作为晚期非小细胞肺癌患者的三线治疗药物：威斯康星州肿瘤网络II期研究
7. Vorinostat (NSC# 701852) in Patients with Relapsed Non-small Cell Lung Cancer: A Wisconsin Oncology Network Phase II Study [O] . Traynor Anne M., Dubey Sarita, Eickhoff Jens C., 2009

机译：Vorinostat（NSC＃701852）在复发性非小细胞肺癌患者中的研究：威斯康星州肿瘤学网络II期研究

Vorinostat and bortezomib as third-line therapy in patients with advanced non-small cell lung cancer: a Wisconsin Oncology Network Phase II study.

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅